ZUZANA SEGEV: Open Payments
NPI 1497155741 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 5 companies in 2025. Trend: 2023 $394 · 2024 $262 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: CAPLYTA, Auvelity, COBENFY, Jornay PM, REXULTI.
Industry payments across FL — which companies pay providers there.
